Breaking News Instant updates and real-time market news.

ANTM

Anthem

$223.64

0.93 (0.42%)

16:48
12/07/17
12/07
16:48
12/07/17
16:48

Anthem increases share repurchase authorization by $5B

In a regulatory filing, Anthem said that, on December 7, 2017, its board increased the company's share repurchase authorization by $5B. As a result, the current total amount available for share repurchases is approximately $7.3B. The company intends to utilize this authorization over a multi-year period, subject to market and industry conditions.

ANTM Anthem
$223.64

0.93 (0.42%)

11/07/17
LEER
11/07/17
NO CHANGE
Target $300
LEER
Outperform
Anthem price target raised to $300 from $245 at Leerink
Leerink analyst Ana Gupte raised her price target for Anthem to $300 from $245 as she sees the appointment of Gail Boudreaux as its next CEO as a "strong driver" of multiple expansion. The analyst reiterates an Outperform rating on the shares.
11/09/17
BARD
11/09/17
NO CHANGE
Target $101
BARD
Outperform
Anthem significantly opens access to Sarepta DMD drug, says Baird
Baird analyst Brian Skorney noted that Anthem (ANTM) has reversed course with its new coverage policy for Sarepta's (SRPT) Duchenne muscular dystrophy drug Exondys 51, as the insurer now considers the drug "medically necessary," compared to its prior view of eteplirsen as "investigational and not medically necessary." This is a significant step in the right direction for Sarepta and points to continued progress on the reimbursement front, Skorney tells investors. He maintains an Outperform rating and $101 price target on Sarepta shares.
11/27/17
LEER
11/27/17
NO CHANGE
Target $280
LEER
Outperform
Cigna most likely acquirer of Humana in any potential transaction, says Leerink
Leerink analyst Ana Gupte notes that a Change of Control 8-K filed by Humana (HUM) suggests that the company is a possible take-out target after the Medicare Advantage Annual Enrollment Season, though the company maintains that this is a needed refresh with broader policy guidelines, rather than individually driven. The analyst sees Cigna (CI) as the most likely acquirer in any potential transaction and able to offer as much as 6% accretion in year 2 and 12% in year 3 post close. However, Anthem (ANTM) and even Wal-Mart (WMT) or Walgreens Boots Alliance (WBA) could be other dark horse acquirers, she contends. Gupte expects that Cigna would need to divest its legacy Health Spring MA assets to satisfy anti-trust regulators, with multiple possible buyers for the assets including WellCare (WCG), Aetna (AET) and Anthem. The analyst reiterates an Outperform rating and $280 price target on Humana shares.
12/06/17
COWN
12/06/17
NO CHANGE
COWN
Tax reform best for Medicare Advantage products, says Cowen
Cowen analyst Christine Arnold reviewed the tax reform implications for the managed care sector and believes the lower tax rate will be most beneficial for Medicare Advantage products as it could allow companies to offset a portion of the non-tax deductible headwind, allowing for stronger margins and/or enhanced benefits for seniors. She believes the lower tax rate would be most positive for Molina (MOH) and WellCare (WCG) given their domestic exposure, but it would also lead to a 15% earnings increase above her projections for Aetna (AET), Anthem (ANTM), Centene (CNC) and Humana (HUM).

TODAY'S FREE FLY STORIES

MO

Altria Group

$58.61

-0.48 (-0.81%)

, BTI

British American Tobacco

$35.55

-0.96 (-2.63%)

11:22
11/15/18
11/15
11:22
11/15/18
11:22
Hot Stocks
CVS 'applauds' FDA announcement to restrict flavored tobacco products »

CVS Health (CVS)…

MO

Altria Group

$58.61

-0.48 (-0.81%)

BTI

British American Tobacco

$35.55

-0.96 (-2.63%)

PM

Philip Morris

$85.26

-0.25 (-0.29%)

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

11:20
11/15/18
11/15
11:20
11/15/18
11:20
General news
Energy Action: NYMEX crude »

Energy Action: NYMEX…

$NSD

NASDAQ Market Internals

$0.00

(0.00%)

11:17
11/15/18
11/15
11:17
11/15/18
11:17
Technical Analysis
NASDAQ market internals summary »

Volume is above average…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

$NYE

NYSE Market Internals

$0.00

(0.00%)

11:16
11/15/18
11/15
11:16
11/15/18
11:16
Technical Analysis
NYSE market internals summary »

Volume is average for…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

MYL

Mylan

$34.69

0.46 (1.34%)

, QRVO

Qorvo

$63.65

0.77 (1.22%)

11:15
11/15/18
11/15
11:15
11/15/18
11:15
OnTheFly
Fly Intel: Today's top analyst calls on Wall Street »

Check out today's top…

MYL

Mylan

$34.69

0.46 (1.34%)

QRVO

Qorvo

$63.65

0.77 (1.22%)

LITE

Lumentum

$39.14

0.29 (0.75%)

AAPL

Apple

$188.37

1.56 (0.84%)

ATNX

Athenex

$10.80

0.52 (5.06%)

PCG

PG&E

$19.54

-6.12 (-23.85%)

HZNP

Horizon Pharma

$20.53

-0.7 (-3.30%)

PYPL

PayPal

$84.29

0.24 (0.29%)

WP

Worldpay

$82.00

-0.71 (-0.86%)

FDC

First Data

$18.00

0.17 (0.95%)

SQ

Square

$70.75

0.9 (1.29%)

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 15

    Nov

  • 26

    Nov

  • 27

    Nov

  • 12

    Dec

  • 18

    Dec

  • 18

    Dec

  • 03

    Mar

MTOR

Meritor

$15.36

-1.95 (-11.27%)

11:12
11/15/18
11/15
11:12
11/15/18
11:12
Recommendations
Meritor analyst commentary  »

Meritor earnings report…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 06

    Dec

  • 13

    Dec

AAPL

Apple

$188.71

1.9 (1.02%)

, LITE

Lumentum

$39.27

0.42 (1.08%)

11:12
11/15/18
11/15
11:12
11/15/18
11:12
OnTheFly
Morgan Stanley says buy Apple on any weakness amid supply chain ‘noise’ »

Calling the recent…

AAPL

Apple

$188.71

1.9 (1.02%)

LITE

Lumentum

$39.27

0.42 (1.08%)

QRVO

Qorvo

$63.84

0.96 (1.53%)

GLW

Corning

$31.59

0.18 (0.57%)

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 26

    Nov

KBH

KB Home

$17.07

-3.73 (-17.93%)

11:10
11/15/18
11/15
11:10
11/15/18
11:10
Options
KB Home puts lead calls 4:1 and implied volatility spikes to 52-week highs »

KB Home puts lead calls…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

11:01
11/15/18
11/15
11:01
11/15/18
11:01
General news
Crude inventories for week of November 9 »

Crude oil inventories…

AUY

Yamana Gold

$2.14

0.015 (0.71%)

11:00
11/15/18
11/15
11:00
11/15/18
11:00
Options
Volatility play in Yamana Gold »

Volatility play in Yamana…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

CLSN

Celsion

$1.99

-0.08 (-3.86%)

10:55
11/15/18
11/15
10:55
11/15/18
10:55
Conference/Events
Celsion to hold a conference call »

Conference Call to…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 15

    Nov

AWI

Armstrong World

$64.99

-1.01 (-1.53%)

10:55
11/15/18
11/15
10:55
11/15/18
10:55
Conference/Events
Armstrong World to hold a conference call »

Conference call to…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 15

    Nov

  • 15

    Nov

  • 16

    Nov

FOXA

21st Century Fox

$47.66

-0.27 (-0.56%)

10:52
11/15/18
11/15
10:52
11/15/18
10:52
Hot Stocks
FOX Sports, Major League Baseball reach new multi-year agreement »

FOX Sports and Major…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

M

Macy's

$31.89

-1.32 (-3.97%)

10:50
11/15/18
11/15
10:50
11/15/18
10:50
Options
Second day of big option prints in Macy's »

Second day of big option…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

WMT

Walmart

$99.47

-2.11 (-2.08%)

10:49
11/15/18
11/15
10:49
11/15/18
10:49
Periodicals
Sanders bill would prevent stock buybacks unless companies pay $15/hr, CNBC says »

Senator Bernie Sanders is…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 15

    Nov

GPRE

Green Plains

$16.94

-0.23 (-1.34%)

, GPP

Green Plains Partners

$14.68

(0.00%)

10:46
11/15/18
11/15
10:46
11/15/18
10:46
Hot Stocks
Green Plains announces permanent closure of Hopewell, VA ethanol facility »

Green Plains (GPRE)…

GPRE

Green Plains

$16.94

-0.23 (-1.34%)

GPP

Green Plains Partners

$14.68

(0.00%)

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

10:45
11/15/18
11/15
10:45
11/15/18
10:45
General news
Breaking General news story  »

6-Month Bill Announcement…

10:45
11/15/18
11/15
10:45
11/15/18
10:45
General news
Breaking General news story  »

Federal Reserve Chairman…

10:45
11/15/18
11/15
10:45
11/15/18
10:45
General news
Breaking General news story  »

3-Month Bill Announcement…

10:45
11/15/18
11/15
10:45
11/15/18
10:45
General news
Breaking General news story  »

Week of 11/9 EIA…

FCE.A

Forest City

$25.25

(0.00%)

, BAM

Brookfield

$43.56

-0.27 (-0.62%)

10:44
11/15/18
11/15
10:44
11/15/18
10:44
Hot Stocks
Forest City stockholders approve acquisition by Brookfield fund »

Forest City Realty Trust…

FCE.A

Forest City

$25.25

(0.00%)

BAM

Brookfield

$43.56

-0.27 (-0.62%)

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 15

    Nov

10:40
11/15/18
11/15
10:40
11/15/18
10:40
Options
Whale of a trade in Invesco Senior Loan ETF »

Whale of a trade in…

10:35
11/15/18
11/15
10:35
11/15/18
10:35
General news
Treasury Option Action: a flurry of call positioning »

Treasury Option Action: a…

DCPH

Deciphera

$22.50

1.88 (9.12%)

, BPMC

Blueprint Medicines

$54.16

-2.22 (-3.94%)

10:32
11/15/18
11/15
10:32
11/15/18
10:32
Recommendations
Deciphera, Blueprint Medicines analyst commentary  »

Deciphera remains well…

DCPH

Deciphera

$22.50

1.88 (9.12%)

BPMC

Blueprint Medicines

$54.16

-2.22 (-3.94%)

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 15

    Nov

  • 27

    Nov

10:30
11/15/18
11/15
10:30
11/15/18
10:30
General news
EIA natural gas storage change for week ending November 9 »

Gas inventories 39 Bcf…

Get Full Fly Access

Breaking market intelligence sent straight to you
Our team of experts analyze every news story and filter out the noise to deliver real-time market moving news.
Up-to-date information on important industry events
Get real-time updates on events that are moving the market—from conferences and calls to syndicate announcements.
News focused on the companies in your portfolio
Create up to 12 portfolios with 150 stocks each, and see how active they are in market news.